Previous studies reported that the peroxisome proliferator-activated receptor α agonist fenofibrate promotes not only hepatic VLDLR expression22 but also steatosis,23 which is in agreement with the phenotype of the LCKD-fed wild-type mice in the present study. The gene discussed is VLDLR; the disease is steatosis.